Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 949 results for "pfizer drugmaker pfizer"

AstraZeneca to Buy Almirall Drugs for $875 Million

AstraZeneca to Buy Almirall Drugs for $875 Million

AstraZeneca Plc (AZN), the U.K. drugmaker that fended off a Pfizer Inc. takeover attempt, agreed to buy the rights to Almirall SA's (ALM) respiratory drugs for $875 million. AstraZeneca will make additional payments of as much as $1.22 billion if ... BusinessWeek, 29 minutes ago

147 images for pfizer drugmaker pfizer

Proactive Investors USA, 14 hours ago
Shreveport Times, 18 hours ago
Irish Times, 1 month ago, 1 week ago
Bioscience Technology Online, 2 months ago, 1 month ago
Irish Times, 1 month ago
Yahoo! News Australia, 1 month ago
San Francisco Chronicle, 2 months ago
MedIndia, 2 months ago

Pfizer: Sales decline hurts revenue

PFIZER, the drugmaker that failed in a bid to buy UK-based AstraZeneca earlier this year, saw second-quarter revenue fall as sales of its drugs decreased, the company said yesterday. Excluding certain items, Pfizer's earnings were 58c a share, 1c ...
 IOL1 hour ago Pfizer's Drug Sales Fall Short as Viagra Struggles  Bloomberg19 hours ago

Pfizer Beats Forecasts Despite Slumping Sales

Pharmaceutical giant Pfizer, Inc. (PFE: Quote), which was aspiring to buy British drug maker AstraZeneca Plc (AZN.L, AZN), reported Tuesday a profit for the second quarter that plunged 79 percent from last year, which reflected hefty gains from ...
 RTTNews.com18 hours ago Cancer drugs boost Pfizer results  Reuters19 hours ago Pfizer Beats the Street  FOXBusiness.com19 hours ago Pfizer beats forecasts as cancer medicine sales grow  Globe and Mail19 hours ago

Pfizer's Q2 profit sinks 79 percent but tops forecasts

NEW YORK: Pfizer's second-quarter earnings plunged 79 percent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion. The latest results still edged analyst expectations. The New York ...
 Arab News9 hours ago Pfizer's profit sinks  IOL16 hours ago Pfizer's 2Q profit sinks 79 pct but tops forecasts  Miami Herald19 hours ago Pfizer's net profit sinks 79 percent  Saudi Gazette6 hours ago

Merck, Pfizer Ramping R&D After Q2 Earnings Beat

Big pharmas Merck and Pfizer modestly beat Q2 estimates early Tuesday, and both guided the full year cautiously as they prepare for new drug launches. Merck stock rose 1.1%, but Pfizer stock fell 1.2%. Merck 's (NYSE: MRK ) earnings totaled 85 ...
 Investor's Business Daily9 hours ago Pfizer, Merck earnings beat Wall St. estimates  USA Today19 hours ago Merck Earnings, Twitter User Growth & EPS, Jim Cramer's New Vale Pick  TheStreet.com19 hours ago Pfizer Merck earnings beat Wall St. estimates  Big News Network12 hours ago

Pfizer CEO Is Impatient for Tax Reform as He Hunts for Deals

July 29 (Bloomberg) -- Failing to buy AstraZeneca Plc with the drug industry's largest-ever deal hasn't stopped Pfizer Inc.'s Ian Read from looking far and wide for acquisitions. We continue to look at all types of business development, regardless ...
 La Repubblica11 hours ago Pfizer CEO Still in the Hunt for Deals and Is Willing to Go Big  La Repubblica14 hours ago Pfizer CEO Still Hunting for Deals and Willing to Go Big  BusinessWeek14 hours ago Pfizer CEO says company "aggressively" seeking deals, does not rule out possible tax inversion  FirstWord Pharma10 hours ago

Pfizer Beats Estimates on Income as Sales Led by Viagra Fall

(Updates with analyst comment in fourth paragraph.) July 29 (Bloomberg) -- Pfizer Inc., the drugmaker that failed in its bid to buy U.K-based AstraZeneca Plc earlier this year, beat analyst estimates by a penny even as revenue fell on declining ...
 La Repubblica18 hours ago

Drugmaker Pfizer's 2nd quarter profit sinks 79 per cent but still beats analyst expectations

, EDT. NEW YORK, N.Y. - Pfizer's second-quarter earnings plunged 79 per cent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion, but results in the most recent quarter still edged ...
 Newstalk 1290 CJBK19 hours ago

Aurobindo, Lupin being sued on generics plans

Multinational drugmakers Pfizer and Forest Laboratories have filed lawsuits against Indian generic company Aurobindo, as it wants to manufacture copycat versions of drugs of which they have patents. Not just Aurobindo, Lupin too is in a similar ...
 Financial Chronicle1 day ago
Business Standard

What are the chances Pfizer will return to AstraZeneca in August?

Citi analysts have ascribed a 25pc probability to the US drugmaker returning to AstraZeneca (NYSE: AZN - news ) next month Pfizer (NYSE: PFE - news ) was forced to walk away from AstraZeneca in May after the spectacular collapse of its £70bn ...
 Yahoo! UK and Ireland1 week ago Pfizer considers raising bid for AstraZeneca - Bloomberg  Business Standard2 months ago AstraZeneca snubs Pfizer?s ?opportunistic? bid  Domain Business2 months ago US, British lawmakers wary of Pfizer?s bid to buy AstraZeneca  Domain Business2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less